News

Find News

Filter articles

Showing 91 to 100 of 2294 results

Federal Circuit upholds ruling in Roche TB patent clash

US10-10-2018

The US Court of Appeals for the Federal Circuit yesterday upheld a district court ruling that invalidated a patent owned by Roche Molecular Systems, a division of Roche that makes equipment and reagents.

Sidley Austin adds partner from King & Spalding

US10-10-2018

Tom Duley has joined Sidley Austin after spending nearly five years at King & Spalding.

Duke University and Allergan drop Alcon dispute

US09-10-2018

North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware.

Canadian generics group hits out at trade deal

Canada, Mexico, US09-10-2018

The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association.

USITC to probe ResMed following Fisher & Paykel complaint

US08-10-2018

The US International Trade Commission has voted to begin an investigation into US medical device maker ResMed following a complaint from New Zealand-based rival Fisher & Paykel Healthcare. 

O’Melveny hires partner from Paul Hastings

US08-10-2018

US-based law firm O’Melveny has hired Hassen Sayeed as a partner in its IP and technology practice group in New York. 

PTAB grants IPR win to Celltrion over Biogen

US05-10-2018

The Patent Trial and Appeal Board invalidated a patent owned by biotech company Biogen yesterday, handing a victory to South Korea-based Celltrion.

Janssen and Arrowhead strike RNAi deal

US05-10-2018

Janssen, a subsidiary of Johnson & Johnson, has entered into a licence and collaboration agreement with drug maker Arrowhead Pharmaceuticals.

MHRA seeks public views on no-deal Brexit

EU, UK04-10-2018

The UK’s Medicines and Healthcare Products Regulatory Agency is seeking industry views on a no-deal Brexit scenario.

Boston Pharma reaches deals with GSK and Novartis

US04-10-2018

Boston Pharmaceuticals yesterday signed deals with GSK and Novartis, licensing eight drug candidates in total.

Showing 91 to 100 of 2294 results

LSIPR